Steroid conjugates, preparation thereof and the use thereof

Details Steroid conjugates, preparation thereof and the use thereof Steroid conjugates, preparation thereof and the use thereof

2003-07-14

2009-02-24

Lukton, David (Department: 1654)

Organic compounds -- part of the class 532-570 series

Organic compounds

Cyclopentanohydrophenanthrene ring system wherein two...

C552S502000, C552S544000, C552S588000, C552S595000, C552S606000, C552S621000, C552S625000, C552S636000, C552S638000, C530S345000, C530S362000, C530S363000

Reexamination Certificate

active

07495115

ABSTRACT:
Conjugates comprising one or more steroids conjugated with one or more mammalian proteins are disclosed. The conjugates are useful for diagnosis or treatment of solid cancer and haematological malignancies. Further the conjugates exhibits a synergistic action together with a cytoskeleton acting drug such as Taxol®, which enable the treatment of cancers that otherwise would be non responsive to Taxol®.

REFERENCES:
patent: 4215102 (1980-07-01), Lee
patent: 4960790 (1990-10-01), Stella et al.
patent: 5157049 (1992-10-01), Haugwitz et al.
patent: 5248796 (1993-09-01), Chen et al.
patent: 5945279 (1999-08-01), O'Malley et al.
patent: 6372712 (2002-04-01), Briesewitz et al.
patent: 6416737 (2002-07-01), Manolagas et al.
patent: 6740304 (2004-05-01), Larsen et al.
patent: 2004/0072776 (2004-04-01), Gleave et al.
patent: 2005/0234027 (2005-10-01), Bothe et al.
patent: 1 104 667 (2001-06-01), None
patent: 2 068 973 (1981-08-01), None
patent: WO 93/02691 (1993-02-01), None
patent: WO 99/13914 (1999-03-01), None
patent: WO 01/82910 (2001-11-01), None
Kampa, Marilena (Experimental Cell Research 307(1), 41-51, 2005).
Brann, et al. (1995) J. Steroid Biochem. Mol. Biol. 52, 113-133.
Grazzini, et al. (1998) Nature 392, 509-512.
Wehling, M. (1997) Annu Rev Physiol 59, 365-93.
Nadal, A., et al. (1998) FASEB J. 12, 1341-1348.
Nemere, I., et al. (1998) Biochem. Biophys. Res. Commun. 248, 443-449.
Jensen, E.V. (1996) Ann. N.Y. Acad. Sci. 748, 1-17.
Kumar, M.V. et al. (1998) Prog. Nucleic Acid Res. Mol. Biol. 59, 289-306.
Benten, P.W., et al. (1999) FASEB J. 13, 123-133.
Benten, P.W. et al. (1997) FEBS Lett 407, 211-214.
Benten, P.W., et al. (1999) Mol. Biol. Cell 10, 3113-23.
Lieberherr, M. et al. (1994) J. Biol. Chem. 269, 7217-7223.
Gorczynska, E. et al. (1995) Endocrinology 136, 2052-9.
Armen, T.A. et al. (2000) J. Cell Biochem 79, 620-7.
Lyng, F.M. et al. (2000) Biol. Reprod 63, 736-47.
Koukouritaki, S.B., et al. (1997) J Cell Biochem 65, 492-500.
Horoszewicz, J.S. et al. (1983) Cancer Res. 43, 1809-1818.
Mosmann T. (1973) J. Immunol. Methods 65, 53-63.
Bradford, M.M. (1976) Anal. Biochem. 72, 248-254.
Golenhofen, N. et al. (1995) Kidney Int. 48, 1837-45.
Auger, K.R. et al. (1989) Cell 57, 167-175.
Singh S.S., et al. (1996) Biochemistry 35, 16544-16549.
Benard, V., et al. (1999) J. Biol. Chem 274, 13198-13204.
Simionescu, L., et al. (1990) Rev. Roum. Endocrinol. 28, 107-125. (XP-008014908).
Ramirez, V. et al. (1996) Cellular and Molecular Neurobiology 16,185-198 (XP-008014894).
Kampa, M. et al. (2002) FASEB 16, 1429-1431.
Papakonstanti, E., et al. (2003) Mol Endocrinol 17, 870-881.
Hatzoglou, Anastassia, et al., Membrane Androgen Receptor Activation Induces Apoptotic Regression of Human Prostate Cancer Cells in Vitro and in Vivo; The Journal of Clinical Endocrinology & Metabolism 90(2):893-803; Copyright 2005 by The Endocrine Society doi: 10.1210/jc.2004-0801.

Affiliated with

Also associated with

Rating

Steroid conjugates, preparation thereof and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Steroid conjugates, preparation thereof and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Steroid conjugates, preparation thereof and the use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4120507